cdp 840 has been researched along with calcimycin in 1 studies
| Studies (cdp 840) | Trials (cdp 840) | Recent Studies (post-2010) (cdp 840) | Studies (calcimycin) | Trials (calcimycin) | Recent Studies (post-2010) (calcimycin) |
|---|---|---|---|---|---|
| 17 | 1 | 0 | 11,946 | 40 | 444 |
| Protein | Taxonomy | cdp 840 (IC50) | calcimycin (IC50) |
|---|---|---|---|
| XBP1 | Homo sapiens (human) | 1.41 | |
| DNA damage-inducible transcript 3 protein | Mus musculus (house mouse) | 0.16 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brideau, C; Chan, CC; Rodger, IW; Styhler, A; Van Staden, C | 1 |
1 other study(ies) available for cdp 840 and calcimycin
| Article | Year |
|---|---|
The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay.
Topics: Calcimycin; Dinoprostone; Female; Humans; Leukotriene B4; Lipopolysaccharides; Male; N-Formylmethionine Leucyl-Phenylalanine; Phosphodiesterase Inhibitors; Pyridines; Tumor Necrosis Factor-alpha | 1999 |